Скачать или смотреть 🎉 BREAKTHROUGH IN ALZHEIMER'S DETECTION! 🧠💉

The FDA just approved the first-ever blood test for Alzheimer’s disease—a major leap in early detection! Developed by Fujirebio Diagnostics, this simple test measures proteins linked to amyloid plaque buildup in the brain, a key marker of Alzheimer’s.

Until now, diagnosis relied on invasive spinal taps or expensive brain scans. Now? Just a blood draw.

With Alzheimer’s projected to double by 2050, this approval could mean earlier treatment with FDA-approved drugs like lecanemab and donanemab—offering patients more time and independence.

Is it a cure? No. But it’s a step toward catching the disease before it steals precious memories.

🧪 Share this with someone who thinks “early signs” don’t apply to them!

#Alzheimers #FDA #BloodTest #HealthNews #EarlyDetection #MedicalBreakthrough #Fujirebio #MemoryMatters